Jessica L Wallace
Overview
Explore the profile of Jessica L Wallace including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
113
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Manis M, Skelley J, Read J, Maxson R, OHagan E, Wallace J, et al.
Ann Pharmacother
. 2024 Apr;
58(12):1238-1248.
PMID: 38563565
Objective: The objective was to explore and describe the role of pharmacists in providing postdischarge care to patients with kidney disease. Data Sources: PubMed, Embase (Elsevier), CINAHL (Ebscohost), Web of...
2.
Fief C, Hoang K, Phipps S, Wallace J, Deweese J
ACS Omega
. 2019 Aug;
4(2):4049-4055.
PMID: 31459613
Fluoroquinolones are a class of widely prescribed antibiotics with a broad range of activity against Gram-positive, Gram-negative, and some atypical microbes. Unfortunately, these drugs are associated with significant adverse events...
3.
Hughes J, Wallace J, Bryant C, Salvig B, Fourakre T, Stone W
Ann Pharmacother
. 2016 Nov;
51(4):301-306.
PMID: 27881692
Background: With the prevalence of and hospitalizations for gout increasing, optimizing care for patients with gout is imperative. The 2012 American College of Rheumatology gout guidelines emphasize that timely monitoring...
4.
Wallace J, Aland K, Blatt K, Moore E, DeFranco E
Am J Obstet Gynecol
. 2016 Nov;
216(3):310.e1-310.e8.
PMID: 27871837
Background: Women with at least 1 prior occurrence of premature birth often have demographic and medical risk factors that are not modifiable. However, smoking cessation could be a targeted intervention...
5.
Self T, Owens R, Sakaan S, Wallace J, Sands C, Howard-Thompson A
Curr Med Res Opin
. 2015 Dec;
32(4):613-20.
PMID: 26695107
Introduction: The purpose of this review article is to summarize the literature on diseases that are documented to have an effect on response to warfarin and other VKAs. Methods: We...
6.
Self T, Wallace J, Sakaan S, Sands C
South Med J
. 2015 Oct;
108(10):637-43.
PMID: 26437201
Objectives: Numerous factors are well documented to affect the response to vitamin K antagonists (VKA), including dietary vitamin K, other drugs, age, pharmacogenetics, and disease states. Body weight is perhaps...
7.
Self T, George C, Wallace J, Patterson S, Finch C
J Asthma
. 2014 Apr;
51(6):566-72.
PMID: 24720711
Background: Monitoring peak expiratory flow (PEF) values is one option as part of asthma action plans per national guidelines. PEF assessment is also recommended in emergency department and hospitalized patients....
8.
Wallace J, Wallace J, McFarland M
Ann Pharmacother
. 2014 Jan;
48(3):361-8.
PMID: 24396092
Objective: To review the available evidence regarding dosing conversion between glargine and detemir in an effort to assist clinicians in performing dosing conversion. Data Sources: A MEDLINE literature search was...
9.
Wallace J, Reaves A, Tolley E, Oliphant C, Hutchison L, Alabdan N, et al.
J Thromb Thrombolysis
. 2012 Sep;
36(1):96-101.
PMID: 23015280
Achieving therapeutic anticoagulation with warfarin is complicated by substantial inter-patient and intra-patient variability with numerous factors known to influence dose requirements. Obesity is one factor for which there remains no...
10.
Self T, Wallace J, Soberman J
J Asthma
. 2012 Sep;
49(9):947-51.
PMID: 22974249
Background: Benefits outweigh risks of cardioselective beta-blocker therapy in patients with nonsevere asthma and a history of heart failure or myocardial infarction (MI). This review summarizes the risks versus benefits...